For example, the sensitivity of a tumor to therapy changes due to the loss of receptors in metastatic and recurrent foci, as well as the acquisition of mutations (for example, ESR1 during hormone therapy with aromatase inhibitors). The gene discussed is CYP19A1; the disease is neoplasm.